Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Metabolic Consequences of Highly Active Antiretroviral Therapy (HAART) in HIV-Positive Individuals

NCT00001102 is registered in ClinicalTrials.gov with National Institute of Allergy and Infectious Diseases (NIAID) as lead sponsor.

NCT NCT00001102
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00001102 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Metabolic Consequences of Highly Active Antiretroviral Therapy (HAART) in HIV-Positive Individuals
Lead sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Phase
Observational
Overall status
Completed
Start date
Not reported
Completion date
June 30, 2006
Enrollment
460
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

hiv infections